Simple endpoint assays for free ubiquitin (Ub) and for the Ub-activating enzyme are described. The method for measuring Ub makes use of the reaction of iodoacetamide-treated Ub-activating enzyme (E): [3H]ATP + Ub + E -* E-[3H]AMP-Ub + PPj and PP1 -* 2Pj (in the presence of pyrophosphatase). The Ub is then measured by determining the acid-insoluble radioactivity. The reaction is accompanied by a slow enzyme-catalyzed hydrolysis of the complex to AMP plus Ub. The presence of ubiquitin-activating enzyme in excess of Ub by -0.1 IAM assures that the steady state will be close to the endpoint for total Ub. A preparation of the activating enzyme from human erythrocytes that does not depend on affinity chromatography is described. Several applications of the assay are presented.
Since its discovery as a highly conserved protein of eukaryotic cells, ubiquitin (Ub) has been found in a variety of cell loci involved in key biological phenomena. In the nucleus, Ub is linked to histones H2A and H2B (1-3). Its presence may be important in gene expression (4, 5) . The amount of Ub linked to these histones changes in a synchronous manner during the stages of the cell cycle (2, 6, 7) . In the cytoplasm, Ub is required in a multienzyme pathway of energy-dependent protein breakdown, again acting by way of a C-terminal isopeptide linkage (8) . Also, the presence in cells of diverse Ub-protein conjugates (9) may indicate that the attachment of Ub plays a role in regulating normal protein function. As a component of cell surface glycoproteins, Ub has a role in cell-cell recognition required for the homing of lymphocytes (10) . Additional specific functions for Ub are suggested by the observation of a number of Ub-carrier proteins (11) and protein-conjugating proteins (12) of unknown function.
In spite of its importance, there is not a convenient assay for Ub. The methods now available require that a sample of Ub be used as a standard, even though Ub is not readily available in pure form. A suitable method should be able to assay Ub itself in the presence of a variety of derivative forms that may be present in a sample. Therefore, for example, an assay based on stimulation of protein breakdown by the reticulocyte system (13) is not generally appropriate since many of the conjugate forms of Ub would be included. An assay method that avoids this problem is based on stimulation of PPi-ATP isotope exchange by highly purified Ub-activating enzyme (14) . This method, being catalytic, is quite sensitive and will not respond to conjugated forms. However, not being an endpoint assay, it requires careful standardization and use of an internal standard to correct for rate effects caused by the sample. Furthermore, the exchange rate is inhibited by Ub at concentrations -1 gM (15) , which might lead to confusion. More complicated methods that depend on variously raised antibodies to Ub (16) or the combination of gel electrophoresis, transfer to nitrocellulose, and immunoblot analysis (9) are valuable in showing the distribution of Ub among different molecular weight species inasmuch as the antibody in use has low specificity, but they do not serve the need for a quantitative assay for Ub per se.
The simple endpoint assay for Ub at the subpicomolar level that we describe here is based on a nearly complete conversion of Ub to AMP-Ub by the Ub-activating enzyme (E). This enzyme, discovered by Hershko and colleagues (14) , carries out the three-step sequence, Eq. 
MATERIALS AND METHODS
Ub and Ub-Activating Enzyme. Preparations of highly purified Ub from human erythrocytes (13) and Ub-activating enzyme from reticulocytes (17) have been reported and are quite reproducible (18, 19) . Purification of the enzyme to homogeneity makes use of its affinity for Ub on a UbSepharose 4B column in the presence of ATP and its specific elution by a solution of AMP and PP1. To obtain good yields of enzyme by this method, it is necessary to decrease the Ub/enzyme ratio from =z100:1 in the lysate to below 1:1 prior to application to the affinity column. This is readily done when rabbit reticulocytes are used, but it has been a problem when starting with human erythrocytes, possibly because of a continuous release of Ub from conjugates during the preparation. A procedure for preparing enzyme for assay purposes has been worked out that replaces the affinity chromatography step with salt-gradient elution on a DE-52 cellulose anion-exchange column followed by separation based on size by chromatography on Sephacryl S-200. 20 ,ul . After a 10-min incubation at 37°C, 1 ml of 12% (vol/vol) trichloroacetic acid is added followed by 0.1 mg of bovine serum albumin. After 5 min on ice, the precipitated AMP-Ub is isolated by centrifugation in a microfuge. The undisturbed pellet is rinsed once with cold 2% (vol/vol) trichloracetic acid and is taken up in 0.1 M NaOH (0.1 ml), and its radioactivity is determined. Under the conditions of the assay with excess Ub, the response is linearly related to the amount of Ub-activating enzyme added up to at least 2 pmol. The fractions within the peak ofactivity, appearing at -150 mM CI-(20) of the gradient, are pooled and precipitated with 80% ammonium sulfate. The pellet is transferred in a minimal volume of 20 mM Tris HCl, pH 7.6/1 mM EDTA/5 mM 2-mercaptoethanol to dialysis tubing and dialyzed against 2 liters of the same buffer overnight.
The dialyzed enzyme from a 50-ml cell preparation is concentrated by lyophilization, if necessary, and is applied in 0.3 ml to a Sephacryl S-200 column (1 x 81 cm) previously equilibrated with 50 mM Tris HCl, pH 7.6/0.2 mM dithiothreitol/0.1 mM EDTA containing ovalbumin (0.05 mg/ml). One-milliliter fractions are collected, and those in the region expected for 100 kDa proteins are assayed for Ub-activating enzyme as above after treating the small aliquots with iodoacetamide. The fractions of high activity are combined and subdivided, and they may be stored at -70'C indefinitely. Recovery of activity in the two column steps is greater than 50%.
Whether the enzyme is prepared by the affinity method or the alternative procedure presented here, it will contain enzymes that liberate Ub from conjugates with simple nucleophiles: thiols, esters, amides, and even from AMP-Ub itself (21, 22) and high molecular weight conjugates. More extreme treatment with iodoacetamide beyond that required to block the sulfhydryl group of Ub-activating enzyme (19) , 10 mM for 20 min at 370C, inactivates these enzymes without altering the assayable activating enzyme. Enzyme treated in this way may be kept at -70'C for several freezing and thawing cycles.
Evidence that the assay of Ub is essentially an endpoint assay is provided in Fig. 1 . The formation of the complex E-AMP-Ub is shown to be rapid under conditions recommended for the assay. A second addition of Ub would give almost the same increment of acid-insoluble cpm as the first. If ATP is removed from the system by means of added hexokinase, and 2-deoxyglucose, the labeled complex disappears with ti12 = 10 min at 37°C (Fig. 1 Inset; k = 1.1 X 10-3 sec-'). This phenomenon and rate are also observed with affinity-purified activating enzyme. The loss of the E-AMPUb complex does not arise from a failure to block the active thiol site in some of the molecules since a single first-order rate constant accounts for decay of the whole population. That Ub is the product of the decay is evident since the assay value obtained does not decrease upon prolonged incubation as long as ATP is present. The breakdown is enzymatic; it is inhibited by EDTA and occurs maximally with as little as 0.1 mM MgCl2. It does not, therefore, represent an abortive transfer of Ub to water, which is a process that does not require Mg2+ (23) , in lieu of the normal sulfhydryl group of the enzyme. It is more likely to be the simple reverse of the first step of Eq. 1 using H20 instead of PPi, which is a Mg2+-dependent step already believed to be of unusually broad specificity as shown by its use of Pi when present at high concentration (23) .
The instability of E*AMP-Ub suggests that its time-independent value in Fig. 1 may be the result of a steady state rather than an endpoint. To determine the extent to which an endpoint has been approached, the data of Fig. 1 In spite of the irreversibility of step 1 (Eq. 1) of the activating enzyme in the presence of pyrophosphatase, the steady-state analysis of the assay requires that the total concentration of Ub-activating enzyme be greater than the concentration of Ub, since free enzyme or rather EATP determines the rate of this step. This is shown in Fig. 2 Ub-activating enzyme treated with iodoacetamide (10 mM, 20 min, and 370C) was accurately assayed as 1.5 pmol per 20 A.l using Ub in "30-fold excess. The unknown was -0.5 pmol/20 t.l using the Ub prepared as described. Samples of 20 p.1 were taken until 10 min at which time yeast hexokinase (Boehringer) and deoxyglucose were added to remove ATP, and sampling was continued. One milliliter of 12% (vol/vol) cold trichloroacetic acid and 100 pug bovine serum albumin (Sigma) were added to each sample. After 5 min on ice, the sample was centrifuged in an Eppendorf microfuge, and the supernatant sample was removed by aspiration. One milliliter of 2% trichloroacetic acid was used as a rinse without mixing. The pellet was dissolved in 0.1 ml of 1 M NaOH and was assayed for radioactivity. The value at 10 min, which was before hexokinase addition, agreed with the 300-sec point.
which E*AMP-Ub was measured at constant Ub and increasing amouflts of Ub-activating enzyme in a 10 min assay. The assay appears to be -75% complete when the total amount 0. of Ub-activating enzyme is in excess of free Ub by -0.4 pmol in the 20-Al assay. This is expected from the rate constants derived above. Further evidence for a proportional response of the assay is shown by the linearity of the plot of acid-insoluble radioactive material versus the volume of an unknown Ub sample added (Fig. 3) . The lower limit range of the assay is determined almost entirely by the presence of Ub in the activating enzyme. Radioactivity that is physically occluded in the precipitate is <0.2% of the total cpm present in the incubation as can be determined by adding an excess of carrier ATP. This represents -0.02 pmol of a Ub-equivalent and can be decreased further by reprecipitation. The Ub present with the enzyme after the two-column procedure is 2-10% of an enzyme equivalent. With an additional purification step to resolve the enzyme from the source of this Ub, the sensitivity of the assay can be increased to 0.02-0.1 pmol, giving 300-1500 cpm above background. This may be done by applying the enzyme to a small DE-cellulose column, washing the column with dilute buffer containing 20 mM KCl, and eluting with 0.5 M KCl as in the first step of the purification.
Routinely our procedure is to make a stock solution, which for 10 assays contains (in 50 ,u1) 2 The assay has been used to examine a number of practical questions: (i) By raising the concentration of Ub-activating enzyme in the assay, the conversion of Ub to E-AMP-Ub can be made proportionately faster than that shown in Fig. 1 
